Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1999 3
2000 3
2001 3
2002 1
2003 2
2004 1
2005 1
2007 2
2008 5
2010 4
2011 1
2012 1
2013 1
2015 1
2016 1
2017 2
2019 2
2020 2
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all
Page 1
Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib.
Showalter LE, Oechsle C, Ghimirey N, Steele C, Czerniecki BJ, Koski GK. Showalter LE, et al. Among authors: koski gk. PLoS One. 2019 Jan 18;14(1):e0210209. doi: 10.1371/journal.pone.0210209. eCollection 2019. PLoS One. 2019. PMID: 30657766 Free PMC article.
Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine.
Basu A, Albert GK, Awshah S, Datta J, Kodumudi KN, Gallen C, Beyer A, Smalley KSM, Rodriguez PC, Duckett DR, Forsyth PA, Soyano A, Koski GK, Lima Barros Costa R, Han H, Soliman H, Lee MC, Kalinski P, Czerniecki BJ. Basu A, et al. Among authors: koski gk. Cancer Immunol Res. 2022 Jan;10(1):108-125. doi: 10.1158/2326-6066.CIR-21-0454. Epub 2021 Nov 16. Cancer Immunol Res. 2022. PMID: 34785506
39 results